Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245M Buy
1,107,790
+423,709
+62% +$117M 1.22% 22
2026
Q1
$202M Sell
684,081
-310,629
-31% -$92.3M 1.04% 27
2025
Q4
$272M Buy
994,710
+14,575
+1% +$3.96M 1.4% 17
2025
Q3
$265M Buy
980,135
+250,186
+34% +$68.1M 1.41% 16
2025
Q2
$201M Buy
729,949
+170,490
+30% +$46.4M 1.11% 24
2025
Q1
$148M Sell
559,459
-270,905
-33% -$66.8M 0.71% 28
2024
Q4
$193M Sell
830,364
-88,358
-10% -$20.3M 1.19% 19
2024
Q3
$203M Sell
918,722
-68,946
-7% -$14.3M 0.73% 22
2024
Q2
$195M Buy
987,668
+259,152
+36% +$53.5M 0.77% 21
2024
Q1
$157M Buy
+728,516
New +$153M 0.59% 29

Other funds holding CME

M&G plc's CME Position: Q2 2026 in Review

M&G plc increased its CME Group (CME) stake by 62% in Q2 2026, buying an estimated $117M and bringing the position to 1,107,790 shares worth $245M. The position accounts for 1.22% of the portfolio, ranked #22.

M&G plc first reported a position in CME in Q1 2024 and has held it in 10 quarters since. The position peaked at $272M in Q4 2025. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • M&G plc held 1,107,790 shares of CME Group worth $245M as of Q2 2026.
  • M&G plc bought 423,709 CME Group shares in Q2 2026, an estimated $117M.
  • CME Group made up 1.22% of M&G plc's portfolio in Q2 2026, its #22 holding.
  • M&G plc first reported a position in CME Group in Q1 2024 and has held it in 10 quarters since.
  • M&G plc's CME Group position peaked at $272M in Q4 2025.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.